Business Archives

Over-the-counter COVID-19 testing now available at CVS Pharmacy

Retailer expands access to convenient, at-home testing options with new-to-market, home tests available in stores and online. WOONSOCKET, R.I., Monday, April 19, 2021 — CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced the availability of three over-the-counter COVID-19 testing options in stores and online. The tests include the Ellume COVID-19 Home Test, […]

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021 Today, digital diagnostics company Ellume highlights the revolutionary technology created in partnership with global product development and technology consultancy firm, Cambridge Consultants, part of the Capgemini Group. Together, the two companies have […]

U.S. strikes $230 million deal for over-the-counter Covid tests

The Biden administration announced a $230 million deal to ramp up production of the country’s first over-the-counter, at-home Covid-19 test. “These are over-the-counter, self-performed test kits that can detect Covid with roughly 95 percent accuracy within 15 minutes,” Andy Slavitt, the White House senior adviser for Covid-19 response, told reporters on Monday.

A fast, at-home coronavirus test will be available to Americans this year

The White House announced Monday it is buying 8.5 million rapid coronavirus tests that can be taken at home without a prescription and that yield immediate results. The $231.8 million contract will allow the Australian company Ellume, which manufacturers the tests, to quickly scale up its production and create a manufacturing facility in the United States.Once running, […]

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.

US Government signs deal to produce Australian COVID-19 Home Test kits

Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with David Koch on Channel 7’s Sunrise program last week to discuss Ellume’s US$231.8 million contract with the U.S. Government to establish a U.S. manufacturing facility and deliver 8.5 million COVID-19 home tests across the U.S in the coming months.

Ellume Announces $231.8 Million Agreement with the U.S. Government

The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S. manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once completed; The investment extends Ellume’s engagement with the U.S. government following the NIH […]

BBC World Service Radio Brisbane Interview with Ellume CEO

17 December 2020, Victoria Craig Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by BBC World Service Radio’s Victoria Craig about our innovative Ellume COVID-19 Home Test receiving Emergency Use Authorization from the US FDA and how our products are responding to the COVID-19 pandemic.

FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

Proven performance in adults and children, with and without symptoms Highlights FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals The test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above Ellume is ramping up manufacture, […]

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Highlights Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home test Clinical study demonstrated overall sensitivity of 95% and specificity of 97% Clinically validated for use in symptomatic and asymptomatic users ages 2 years and above Independently run, simulated home-use clinical study of 198 subjects Ellume is […]

Page 1 of 412 3 4